scholarly article | Q13442814 |
P50 | author | Rajiv Khanna | Q37838228 |
Scott R Burrows | Q55457028 | ||
P2093 | author name string | D J Moss | |
I S Misko | |||
S L Silins | |||
V P Argaet | |||
P2860 | cites work | Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain | Q24610546 |
Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb | Q27642080 | ||
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition | Q27642083 | ||
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection | Q27729346 | ||
The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 | Q27729917 | ||
The molecular basis of allorecognition | Q28268279 | ||
T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
T-cell antigen receptor genes and T-cell recognition | Q29619721 | ||
Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5' ends of mRNAs and for constructing cDNA libraries by in vitro amplification | Q33411736 | ||
Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses | Q33863544 | ||
The human T cell receptor in health and disease | Q36135257 | ||
The V beta 17+ T cell repertoire: skewed J beta usage after thymic selection; dissimilar CDR3s in CD4+ versus CD8+ cells | Q36230603 | ||
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells | Q57000154 | ||
Emerging principles for the recognition of peptide antigens by MHC class I molecules | Q67494475 | ||
The specificity of recognition of a cytotoxic T lymphocyte epitope | Q67530991 | ||
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas | Q67894766 | ||
The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC | Q68045564 | ||
Synthesis of peptide analogues using the multipin peptide synthesis method | Q68059545 | ||
Autoimmune diseases: the failure of self tolerance | Q68090705 | ||
The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire | Q69104366 | ||
Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli | Q70328740 | ||
Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses | Q70464149 | ||
Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues | Q70482144 | ||
Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27 | Q71649941 | ||
Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction | Q72090171 | ||
In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment | Q36231548 | ||
T cell clones specific for an amphipathic alpha-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides. A multiview/single structure interpretation of immunodominance | Q36353024 | ||
Mechanisms influencing the immunodominance of T cell determinants | Q36355734 | ||
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease | Q36362943 | ||
Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice | Q36363704 | ||
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. | Q36364099 | ||
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment | Q36364315 | ||
Reactivation of Epstein-Barr virus in Sjögren's syndrome. | Q36464555 | ||
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules | Q36741865 | ||
Site‐specific recombination in the immune system 1 | Q36831022 | ||
Ligation-anchored PCR: a simple amplification technique with single-sided specificity | Q37255156 | ||
Limitations in plasticity of the T-cell receptor repertoire | Q37611185 | ||
Is T-cell memory maintained by crossreactive stimulation? | Q37931996 | ||
Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics | Q38330987 | ||
The T cell receptor | Q39682077 | ||
Recognition of Self and Regulation of Specificity at the Level of Cell Populations | Q40110807 | ||
The evaluation of limiting dilution assays | Q40328249 | ||
Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes | Q40393835 | ||
Ligands for the T-cell receptor: hard times for avidity models | Q40543526 | ||
Antigen analogs/MHC complexes as specific T cell receptor antagonists | Q40661137 | ||
Negative selection of lymphocytes | Q40807431 | ||
MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
Superantigens and their potential role in human disease | Q40858079 | ||
Antigen-selected T-cell receptor diversity and self-nonself homology | Q40858305 | ||
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. | Q41030813 | ||
The outline structure of the T-cell alpha beta receptor. | Q41094902 | ||
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells | Q41608848 | ||
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3) | Q41757439 | ||
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants | Q42068985 | ||
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site | Q42546164 | ||
Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers | Q44501830 | ||
T Cell Reactivity to MHC Molecules: Immunity Versus Tolerance | Q44650657 | ||
Atomic structure of a human MHC molecule presenting an influenza virus peptide | Q44667197 | ||
Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times | Q44908446 | ||
Failure to find holes in the T-cell repertoire | Q45145021 | ||
Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 | ||
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides | Q45285705 | ||
Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus | Q45873907 | ||
Unresponsiveness to a foreign antigen can be caused by self-tolerance | Q46860879 | ||
Peptide selection by class I molecules of the major histocompatibility complex | Q47981861 | ||
Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells | Q48076140 | ||
Characterization of the human T cell receptor alpha-chain repertoire and demonstration of a genetic influence on V alpha usage | Q48121902 | ||
Alternative T cell receptor gene usage induced by self tolerance. | Q52867185 | ||
Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. | Q52885902 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1703-1715 | |
P577 | publication date | 1995-12-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen | |
P478 | volume | 182 |
Q27641906 | A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition |
Q34044757 | A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy |
Q37038492 | A complex interaction between drug allergy and viral infection |
Q41007124 | A dominant V beta bias in the CTL response after HSV-1 infection is determined by peptide residues predicted to also interact with the TCR beta-chain CDR3. |
Q39127824 | A public T cell receptor recognized by a monoclonal antibody specific for the D-J junction of the β-chain. |
Q27641421 | A structural basis for immunodominant human T cell receptor recognition |
Q27640322 | A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity |
Q38050479 | A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned |
Q39548736 | Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells. |
Q41533770 | Advances in T-cell epitope engineering |
Q37966022 | Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure |
Q27662550 | Allelic polymorphism in the T cell receptor and its impact on immune responses |
Q40278935 | Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals |
Q35000627 | Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells. |
Q44323172 | Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry |
Q37769912 | Alloreactivity from human viral specific memory T-cells |
Q33754153 | Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice. |
Q37110627 | An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP. |
Q60603232 | Analysis of the peripheral T-cell repertoire in kidney transplant patients |
Q37837483 | Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination |
Q35766280 | Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection |
Q42263480 | Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection. |
Q43681352 | Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference |
Q45733325 | Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus |
Q26752289 | Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation |
Q60046087 | Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome |
Q41101622 | Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity |
Q38204912 | Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review |
Q41103096 | Cytotoxic T lymphocyte responses to Epstein-Barr virus |
Q39876670 | Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants |
Q37145510 | Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. |
Q33246123 | Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide |
Q34446000 | Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture |
Q21092234 | Design and pre-clinical evaluation of a universal HIV-1 vaccine |
Q40901873 | Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. |
Q35012614 | Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function |
Q42034088 | Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus |
Q37754754 | Factors influencing immunodominance hierarchies in TCD8+ -mediated antiviral responses |
Q27666160 | Genetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus Infection |
Q35166836 | HIV vaccines 1983-2003. |
Q27661747 | Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability |
Q54247364 | Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. |
Q35927610 | Heterogeneity within T Cell Memory: Implications for Transplant Tolerance |
Q33707543 | Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition |
Q52045269 | Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. |
Q42129294 | Immune parameters to consider when choosing T-cell receptors for therapy |
Q36689912 | Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor |
Q74334962 | Immunodominant minor histocompatibility antigens: the major ones |
Q48962568 | In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing |
Q33259057 | Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques |
Q45286056 | Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations |
Q27485186 | Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape |
Q84498369 | Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host |
Q41955439 | MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs. |
Q93386500 | Models of immune selection for multi-locus antigenic diversity of pathogens |
Q40653042 | Molecular mimicry: can epitope mimicry induce autoimmune disease? |
Q54697860 | Multiple T-cell clones specific for the same foreign pMHC ligand can be generated from a single, ancestral TCR-VDJbeta precursor. |
Q37105892 | Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus |
Q78022698 | Oligoclonal T cells in human cancer |
Q36273291 | Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations |
Q51040397 | Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions. |
Q24657081 | Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis |
Q33608371 | Predicting alloreactivity in transplantation |
Q40626780 | Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. |
Q37273289 | Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection |
Q47564568 | Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles |
Q37316838 | Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant |
Q36655911 | Structural determinants of T-cell receptor bias in immunity |
Q40841744 | Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage |
Q55436826 | T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice. |
Q36399643 | T cell cross-reactivity and conformational changes during TCR engagement |
Q36370531 | T cell receptor gene rearrangement lineage analysis reveals clues for the origin of highly restricted antigen-specific repertoires |
Q40368484 | T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide |
Q33676064 | T cell receptor usage in infectious disease |
Q34718133 | T-cell-receptor gene therapy |
Q37965366 | TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. |
Q27639950 | The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance |
Q35119207 | The Evolution of Antigen-Specific CD8+T Cell Responses after Natural Primary Infection of Humans with Epstein-Barr Virus |
Q90346271 | The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide |
Q41593996 | The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized |
Q33958500 | The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome |
Q36403686 | The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation |
Q34225567 | The immunology of Epstein-Barr virus infection |
Q56917311 | The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV |
Q33632723 | The influence of antiviral T-cell responses on the alloreactive repertoire. |
Q34632089 | The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? |
Q56914419 | The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: Steric hindrance influences TCR allo-recognition |
Q36919171 | Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity |
Q89050971 | Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells |
Q51005517 | Transplantation tolerance: memories that haunt us. |
Q35921697 | Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer |
Q42615546 | Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients. |
Search more.